Published in Cancer Weekly, February 28th, 2006
"[The study's aim was] to investigate the potential of genetic polymorphism (Pro198Leu) in the hGPX1 gene as a biologic marker predictive of bladder cancer recurrence. Given the high propensity for superficial bladder cancer recurrence, biologic markers that are predictive of recurrence may provide additional helpful information in bladder cancer treatment," investigators in the United States reported.
"To date, few valuable molecular markers have been closely associated with bladder cancer recurrence. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.